Lack of Association Between Neurohormonal Blockade and Survival in Transthyretin Cardiac Amyloidosis

BACKGROUND: Despite the belief that heart failure therapies are not effective in transthyretin cardiac amyloidosis, data are limited. We tested the association of neurohormonal blockade use with survival. METHODS AND RESULTS: A total of 309 consecutive patients with transthyretin cardiac amyloidosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Richard K., Vasbinder, Alexi, Levy, Wayne C., Goyal, Parag, Griffin, Jan M., Leedy, Douglas J., Maurer, Mathew S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075255/
https://www.ncbi.nlm.nih.gov/pubmed/34729989
http://dx.doi.org/10.1161/JAHA.121.022859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075255/
https://www.ncbi.nlm.nih.gov/pubmed/34729989
http://dx.doi.org/10.1161/JAHA.121.022859

Ejemplares similares